Promacta
by GlaxoSmithKline (GSK)
According to the National Cancer Institute, Promacta (eltrombopag) is prescribed to adults and children with severe aplastic anemia. It’s also prescribed for thrombocytopenia (low blood platelet count...
According to the National Cancer Institute, Promacta (eltrombopag) is prescribed to adults and children with severe aplastic anemia. It’s also prescribed for thrombocytopenia (low blood platelet count) in adults and children with chronic immune thrombocytopenic purpura (ITP) that has not responded to other treatment.
In its tablet form, Promacta is taken once daily by mouth:
Patient assistance programs
Promacta Patient Assistance Program
Manufacturer PAP- Eligibility
- Patients who meet income and insurance requirements
- Income limit
- Varies — contact ClariMeds for current limits
- Insurance
- Typically uninsured or underinsured; Medicare/Medicaid restrictions may apply
- How to apply
- Apply through ClariMeds — we handle the paperwork at no cost
Need help applying?
ClariMeds handles the entire application process for you — for free. See if you qualify in minutes.
See If You Qualify — Free